Agriculture
Fumonisins Immunoaffinity Columns (IAC) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 660278
- Pages: 167
- Figures: 283
- Views: 6
Fumonisins Immunoaffinity Columns (IACs) are specialized chromatographic columns used for the extraction and purification of fumonisins from various samples. Fumonisins are a group of mycotoxins produced primarily by the fungi Fusarium verticillioides and Fusarium proliferatum. They commonly contaminate maize (corn) and related products.
The global market for Fumonisins Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Fumonisins Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fumonisins Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Fumonisins Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Fumonisins Immunoaffinity Columns (IAC) include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG and CHROMATIFIC, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fumonisins Immunoaffinity Columns (IAC), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fumonisins Immunoaffinity Columns (IAC) by region & country, by Type, and by Application.
The Fumonisins Immunoaffinity Columns (IAC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fumonisins Immunoaffinity Columns (IAC).
Market Segmentation
By Company
Gold Standard Diagnostics Horsham
LCTech
Shimadzu
Biotez Berlin
PerkinElmer
VICAM
Ring Biotechnology
R-Biopharm AG
CHROMATIFIC
Neogen
Shandong Meizheng Bio-Tech
Pribolab
Jiangsu Suwei Micro-Biology Research
Shandong Lvdu Bio-Sciences & Technology
Jiangsu Wisdom Engineering & Technology
BIOCOMMA
Femdetection
Wuhan Huamei Wisherkon Biotech
Changsha Huaxue Biological Technology
Anavo
Shandong Vnya Bio-technology
Guanyibio
Prufunglab
Segment by Type:
80% Below
80-90%
91-100%
100% Above
Segment by Application
Grains
Feed
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fumonisins Immunoaffinity Columns (IAC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fumonisins Immunoaffinity Columns (IAC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fumonisins Immunoaffinity Columns (IAC) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Fumonisins Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Fumonisins Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fumonisins Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Fumonisins Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Fumonisins Immunoaffinity Columns (IAC) include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG and CHROMATIFIC, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fumonisins Immunoaffinity Columns (IAC), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fumonisins Immunoaffinity Columns (IAC) by region & country, by Type, and by Application.
The Fumonisins Immunoaffinity Columns (IAC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fumonisins Immunoaffinity Columns (IAC).
Market Segmentation
By Company
Gold Standard Diagnostics Horsham
LCTech
Shimadzu
Biotez Berlin
PerkinElmer
VICAM
Ring Biotechnology
R-Biopharm AG
CHROMATIFIC
Neogen
Shandong Meizheng Bio-Tech
Pribolab
Jiangsu Suwei Micro-Biology Research
Shandong Lvdu Bio-Sciences & Technology
Jiangsu Wisdom Engineering & Technology
BIOCOMMA
Femdetection
Wuhan Huamei Wisherkon Biotech
Changsha Huaxue Biological Technology
Anavo
Shandong Vnya Bio-technology
Guanyibio
Prufunglab
Segment by Type:
80% Below
80-90%
91-100%
100% Above
Segment by Application
Grains
Feed
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fumonisins Immunoaffinity Columns (IAC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fumonisins Immunoaffinity Columns (IAC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fumonisins Immunoaffinity Columns (IAC) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Fumonisins Immunoaffinity Columns (IAC) Product Introduction
1.2 Global Fumonisins Immunoaffinity Columns (IAC) Market Size Forecast
1.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030)
1.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume (2019-2030)
1.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Price (2019-2030)
1.3 Fumonisins Immunoaffinity Columns (IAC) Market Trends & Drivers
1.3.1 Fumonisins Immunoaffinity Columns (IAC) Industry Trends
1.3.2 Fumonisins Immunoaffinity Columns (IAC) Market Drivers & Opportunity
1.3.3 Fumonisins Immunoaffinity Columns (IAC) Market Challenges
1.3.4 Fumonisins Immunoaffinity Columns (IAC) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fumonisins Immunoaffinity Columns (IAC) Players Revenue Ranking (2023)
2.2 Global Fumonisins Immunoaffinity Columns (IAC) Revenue by Company (2019-2024)
2.3 Global Fumonisins Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2023)
2.4 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Company Players (2019-2024)
2.5 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Company (2019-2024)
2.6 Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fumonisins Immunoaffinity Columns (IAC)
2.9 Fumonisins Immunoaffinity Columns (IAC) Market Competitive Analysis
2.9.1 Fumonisins Immunoaffinity Columns (IAC) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Fumonisins Immunoaffinity Columns (IAC) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fumonisins Immunoaffinity Columns (IAC) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 80% Below
3.1.2 80-90%
3.1.3 91-100%
3.1.4 100% Above
3.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type
3.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Type (2019-2030)
3.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Type (%) (2019-2030)
3.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type
3.3.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Type (2019-2030)
3.3.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Type (%) (2019-2030)
3.4 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Grains
4.1.2 Feed
4.1.3 Others
4.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application
4.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Application (2019-2030)
4.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Application (%) (2019-2030)
4.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application
4.3.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Application (2019-2030)
4.3.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Application (%) (2019-2030)
4.4 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region
5.1.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024)
5.1.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030)
5.1.4 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (%), (2019-2030)
5.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region
5.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024)
5.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030)
5.2.4 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (%), (2019-2030)
5.3 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.4.2 North America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.5.2 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.6.2 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.7.2 South America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.8.2 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value
6.2.1 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.3.2 United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.4.2 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.5.2 China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.6.2 Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.7.2 South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.8.2 Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.9.2 India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gold Standard Diagnostics Horsham
7.1.1 Gold Standard Diagnostics Horsham Company Information
7.1.2 Gold Standard Diagnostics Horsham Introduction and Business Overview
7.1.3 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.1.5 Gold Standard Diagnostics Horsham Recent Development
7.2 LCTech
7.2.1 LCTech Company Information
7.2.2 LCTech Introduction and Business Overview
7.2.3 LCTech Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 LCTech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.2.5 LCTech Recent Development
7.3 Shimadzu
7.3.1 Shimadzu Company Information
7.3.2 Shimadzu Introduction and Business Overview
7.3.3 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.3.5 Shimadzu Recent Development
7.4 Biotez Berlin
7.4.1 Biotez Berlin Company Information
7.4.2 Biotez Berlin Introduction and Business Overview
7.4.3 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.4.5 Biotez Berlin Recent Development
7.5 PerkinElmer
7.5.1 PerkinElmer Company Information
7.5.2 PerkinElmer Introduction and Business Overview
7.5.3 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.5.5 PerkinElmer Recent Development
7.6 VICAM
7.6.1 VICAM Company Information
7.6.2 VICAM Introduction and Business Overview
7.6.3 VICAM Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 VICAM Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.6.5 VICAM Recent Development
7.7 Ring Biotechnology
7.7.1 Ring Biotechnology Company Information
7.7.2 Ring Biotechnology Introduction and Business Overview
7.7.3 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.7.5 Ring Biotechnology Recent Development
7.8 R-Biopharm AG
7.8.1 R-Biopharm AG Company Information
7.8.2 R-Biopharm AG Introduction and Business Overview
7.8.3 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.8.5 R-Biopharm AG Recent Development
7.9 CHROMATIFIC
7.9.1 CHROMATIFIC Company Information
7.9.2 CHROMATIFIC Introduction and Business Overview
7.9.3 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.9.5 CHROMATIFIC Recent Development
7.10 Neogen
7.10.1 Neogen Company Information
7.10.2 Neogen Introduction and Business Overview
7.10.3 Neogen Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Neogen Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.10.5 Neogen Recent Development
7.11 Shandong Meizheng Bio-Tech
7.11.1 Shandong Meizheng Bio-Tech Company Information
7.11.2 Shandong Meizheng Bio-Tech Introduction and Business Overview
7.11.3 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.11.5 Shandong Meizheng Bio-Tech Recent Development
7.12 Pribolab
7.12.1 Pribolab Company Information
7.12.2 Pribolab Introduction and Business Overview
7.12.3 Pribolab Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Pribolab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.12.5 Pribolab Recent Development
7.13 Jiangsu Suwei Micro-Biology Research
7.13.1 Jiangsu Suwei Micro-Biology Research Company Information
7.13.2 Jiangsu Suwei Micro-Biology Research Introduction and Business Overview
7.13.3 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.13.5 Jiangsu Suwei Micro-Biology Research Recent Development
7.14 Shandong Lvdu Bio-Sciences & Technology
7.14.1 Shandong Lvdu Bio-Sciences & Technology Company Information
7.14.2 Shandong Lvdu Bio-Sciences & Technology Introduction and Business Overview
7.14.3 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Development
7.15 Jiangsu Wisdom Engineering & Technology
7.15.1 Jiangsu Wisdom Engineering & Technology Company Information
7.15.2 Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
7.15.3 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.15.5 Jiangsu Wisdom Engineering & Technology Recent Development
7.16 BIOCOMMA
7.16.1 BIOCOMMA Company Information
7.16.2 BIOCOMMA Introduction and Business Overview
7.16.3 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.16.5 BIOCOMMA Recent Development
7.17 Femdetection
7.17.1 Femdetection Company Information
7.17.2 Femdetection Introduction and Business Overview
7.17.3 Femdetection Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Femdetection Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.17.5 Femdetection Recent Development
7.18 Wuhan Huamei Wisherkon Biotech
7.18.1 Wuhan Huamei Wisherkon Biotech Company Information
7.18.2 Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
7.18.3 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.18.5 Wuhan Huamei Wisherkon Biotech Recent Development
7.19 Changsha Huaxue Biological Technology
7.19.1 Changsha Huaxue Biological Technology Company Information
7.19.2 Changsha Huaxue Biological Technology Introduction and Business Overview
7.19.3 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.19.5 Changsha Huaxue Biological Technology Recent Development
7.20 Anavo
7.20.1 Anavo Company Information
7.20.2 Anavo Introduction and Business Overview
7.20.3 Anavo Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Anavo Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.20.5 Anavo Recent Development
7.21 Shandong Vnya Bio-technology
7.21.1 Shandong Vnya Bio-technology Company Information
7.21.2 Shandong Vnya Bio-technology Introduction and Business Overview
7.21.3 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.21.5 Shandong Vnya Bio-technology Recent Development
7.22 Guanyibio
7.22.1 Guanyibio Company Information
7.22.2 Guanyibio Introduction and Business Overview
7.22.3 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.22.5 Guanyibio Recent Development
7.23 Prufunglab
7.23.1 Prufunglab Company Information
7.23.2 Prufunglab Introduction and Business Overview
7.23.3 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.23.5 Prufunglab Recent Development
8 Industry Chain Analysis
8.1 Fumonisins Immunoaffinity Columns (IAC) Industrial Chain
8.2 Fumonisins Immunoaffinity Columns (IAC) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fumonisins Immunoaffinity Columns (IAC) Sales Model
8.5.2 Sales Channel
8.5.3 Fumonisins Immunoaffinity Columns (IAC) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Fumonisins Immunoaffinity Columns (IAC) Product Introduction
1.2 Global Fumonisins Immunoaffinity Columns (IAC) Market Size Forecast
1.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030)
1.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume (2019-2030)
1.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Price (2019-2030)
1.3 Fumonisins Immunoaffinity Columns (IAC) Market Trends & Drivers
1.3.1 Fumonisins Immunoaffinity Columns (IAC) Industry Trends
1.3.2 Fumonisins Immunoaffinity Columns (IAC) Market Drivers & Opportunity
1.3.3 Fumonisins Immunoaffinity Columns (IAC) Market Challenges
1.3.4 Fumonisins Immunoaffinity Columns (IAC) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fumonisins Immunoaffinity Columns (IAC) Players Revenue Ranking (2023)
2.2 Global Fumonisins Immunoaffinity Columns (IAC) Revenue by Company (2019-2024)
2.3 Global Fumonisins Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2023)
2.4 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Company Players (2019-2024)
2.5 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Company (2019-2024)
2.6 Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fumonisins Immunoaffinity Columns (IAC)
2.9 Fumonisins Immunoaffinity Columns (IAC) Market Competitive Analysis
2.9.1 Fumonisins Immunoaffinity Columns (IAC) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Fumonisins Immunoaffinity Columns (IAC) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fumonisins Immunoaffinity Columns (IAC) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 80% Below
3.1.2 80-90%
3.1.3 91-100%
3.1.4 100% Above
3.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type
3.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Type (2019-2030)
3.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Type (%) (2019-2030)
3.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type
3.3.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Type (2019-2030)
3.3.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Type (%) (2019-2030)
3.4 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Grains
4.1.2 Feed
4.1.3 Others
4.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application
4.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Application (2019-2030)
4.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, by Application (%) (2019-2030)
4.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application
4.3.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Application (2019-2030)
4.3.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume, by Application (%) (2019-2030)
4.4 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region
5.1.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024)
5.1.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030)
5.1.4 Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (%), (2019-2030)
5.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region
5.2.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024)
5.2.3 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030)
5.2.4 Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (%), (2019-2030)
5.3 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.4.2 North America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.5.2 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.6.2 Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.7.2 South America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.8.2 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value
6.2.1 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.3.2 United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.4.2 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.5.2 China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.6.2 Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.7.2 South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.8.2 Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.9.2 India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gold Standard Diagnostics Horsham
7.1.1 Gold Standard Diagnostics Horsham Company Information
7.1.2 Gold Standard Diagnostics Horsham Introduction and Business Overview
7.1.3 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.1.5 Gold Standard Diagnostics Horsham Recent Development
7.2 LCTech
7.2.1 LCTech Company Information
7.2.2 LCTech Introduction and Business Overview
7.2.3 LCTech Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 LCTech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.2.5 LCTech Recent Development
7.3 Shimadzu
7.3.1 Shimadzu Company Information
7.3.2 Shimadzu Introduction and Business Overview
7.3.3 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.3.5 Shimadzu Recent Development
7.4 Biotez Berlin
7.4.1 Biotez Berlin Company Information
7.4.2 Biotez Berlin Introduction and Business Overview
7.4.3 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.4.5 Biotez Berlin Recent Development
7.5 PerkinElmer
7.5.1 PerkinElmer Company Information
7.5.2 PerkinElmer Introduction and Business Overview
7.5.3 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.5.5 PerkinElmer Recent Development
7.6 VICAM
7.6.1 VICAM Company Information
7.6.2 VICAM Introduction and Business Overview
7.6.3 VICAM Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 VICAM Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.6.5 VICAM Recent Development
7.7 Ring Biotechnology
7.7.1 Ring Biotechnology Company Information
7.7.2 Ring Biotechnology Introduction and Business Overview
7.7.3 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.7.5 Ring Biotechnology Recent Development
7.8 R-Biopharm AG
7.8.1 R-Biopharm AG Company Information
7.8.2 R-Biopharm AG Introduction and Business Overview
7.8.3 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.8.5 R-Biopharm AG Recent Development
7.9 CHROMATIFIC
7.9.1 CHROMATIFIC Company Information
7.9.2 CHROMATIFIC Introduction and Business Overview
7.9.3 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.9.5 CHROMATIFIC Recent Development
7.10 Neogen
7.10.1 Neogen Company Information
7.10.2 Neogen Introduction and Business Overview
7.10.3 Neogen Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Neogen Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.10.5 Neogen Recent Development
7.11 Shandong Meizheng Bio-Tech
7.11.1 Shandong Meizheng Bio-Tech Company Information
7.11.2 Shandong Meizheng Bio-Tech Introduction and Business Overview
7.11.3 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.11.5 Shandong Meizheng Bio-Tech Recent Development
7.12 Pribolab
7.12.1 Pribolab Company Information
7.12.2 Pribolab Introduction and Business Overview
7.12.3 Pribolab Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Pribolab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.12.5 Pribolab Recent Development
7.13 Jiangsu Suwei Micro-Biology Research
7.13.1 Jiangsu Suwei Micro-Biology Research Company Information
7.13.2 Jiangsu Suwei Micro-Biology Research Introduction and Business Overview
7.13.3 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.13.5 Jiangsu Suwei Micro-Biology Research Recent Development
7.14 Shandong Lvdu Bio-Sciences & Technology
7.14.1 Shandong Lvdu Bio-Sciences & Technology Company Information
7.14.2 Shandong Lvdu Bio-Sciences & Technology Introduction and Business Overview
7.14.3 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Development
7.15 Jiangsu Wisdom Engineering & Technology
7.15.1 Jiangsu Wisdom Engineering & Technology Company Information
7.15.2 Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
7.15.3 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.15.5 Jiangsu Wisdom Engineering & Technology Recent Development
7.16 BIOCOMMA
7.16.1 BIOCOMMA Company Information
7.16.2 BIOCOMMA Introduction and Business Overview
7.16.3 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.16.5 BIOCOMMA Recent Development
7.17 Femdetection
7.17.1 Femdetection Company Information
7.17.2 Femdetection Introduction and Business Overview
7.17.3 Femdetection Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Femdetection Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.17.5 Femdetection Recent Development
7.18 Wuhan Huamei Wisherkon Biotech
7.18.1 Wuhan Huamei Wisherkon Biotech Company Information
7.18.2 Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
7.18.3 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.18.5 Wuhan Huamei Wisherkon Biotech Recent Development
7.19 Changsha Huaxue Biological Technology
7.19.1 Changsha Huaxue Biological Technology Company Information
7.19.2 Changsha Huaxue Biological Technology Introduction and Business Overview
7.19.3 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.19.5 Changsha Huaxue Biological Technology Recent Development
7.20 Anavo
7.20.1 Anavo Company Information
7.20.2 Anavo Introduction and Business Overview
7.20.3 Anavo Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Anavo Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.20.5 Anavo Recent Development
7.21 Shandong Vnya Bio-technology
7.21.1 Shandong Vnya Bio-technology Company Information
7.21.2 Shandong Vnya Bio-technology Introduction and Business Overview
7.21.3 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.21.5 Shandong Vnya Bio-technology Recent Development
7.22 Guanyibio
7.22.1 Guanyibio Company Information
7.22.2 Guanyibio Introduction and Business Overview
7.22.3 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.22.5 Guanyibio Recent Development
7.23 Prufunglab
7.23.1 Prufunglab Company Information
7.23.2 Prufunglab Introduction and Business Overview
7.23.3 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
7.23.5 Prufunglab Recent Development
8 Industry Chain Analysis
8.1 Fumonisins Immunoaffinity Columns (IAC) Industrial Chain
8.2 Fumonisins Immunoaffinity Columns (IAC) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fumonisins Immunoaffinity Columns (IAC) Sales Model
8.5.2 Sales Channel
8.5.3 Fumonisins Immunoaffinity Columns (IAC) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Fumonisins Immunoaffinity Columns (IAC) Market Trends
Table 2. Fumonisins Immunoaffinity Columns (IAC) Market Drivers & Opportunity
Table 3. Fumonisins Immunoaffinity Columns (IAC) Market Challenges
Table 4. Fumonisins Immunoaffinity Columns (IAC) Market Restraints
Table 5. Global Fumonisins Immunoaffinity Columns (IAC) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Fumonisins Immunoaffinity Columns (IAC) Revenue Market Share by Company (2019-2024)
Table 7. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Fumonisins Immunoaffinity Columns (IAC) Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Fumonisins Immunoaffinity Columns (IAC)
Table 13. Global Fumonisins Immunoaffinity Columns (IAC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fumonisins Immunoaffinity Columns (IAC) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024) & (%)
Table 44. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030) & (%)
Table 45. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume, (2025-2030) & (K Units)
Table 57. Gold Standard Diagnostics Horsham Company Information
Table 58. Gold Standard Diagnostics Horsham Introduction and Business Overview
Table 59. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 61. Gold Standard Diagnostics Horsham Recent Development
Table 62. LCTech Company Information
Table 63. LCTech Introduction and Business Overview
Table 64. LCTech Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. LCTech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 66. LCTech Recent Development
Table 67. Shimadzu Company Information
Table 68. Shimadzu Introduction and Business Overview
Table 69. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 71. Shimadzu Recent Development
Table 72. Biotez Berlin Company Information
Table 73. Biotez Berlin Introduction and Business Overview
Table 74. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 76. Biotez Berlin Recent Development
Table 77. PerkinElmer Company Information
Table 78. PerkinElmer Introduction and Business Overview
Table 79. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 81. PerkinElmer Recent Development
Table 82. VICAM Company Information
Table 83. VICAM Introduction and Business Overview
Table 84. VICAM Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. VICAM Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 86. VICAM Recent Development
Table 87. Ring Biotechnology Company Information
Table 88. Ring Biotechnology Introduction and Business Overview
Table 89. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 91. Ring Biotechnology Recent Development
Table 92. R-Biopharm AG Company Information
Table 93. R-Biopharm AG Introduction and Business Overview
Table 94. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 96. R-Biopharm AG Recent Development
Table 97. CHROMATIFIC Company Information
Table 98. CHROMATIFIC Introduction and Business Overview
Table 99. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 101. CHROMATIFIC Recent Development
Table 102. Neogen Company Information
Table 103. Neogen Introduction and Business Overview
Table 104. Neogen Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Neogen Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 106. Neogen Recent Development
Table 107. Shandong Meizheng Bio-Tech Company Information
Table 108. Shandong Meizheng Bio-Tech Introduction and Business Overview
Table 109. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 111. Shandong Meizheng Bio-Tech Recent Development
Table 112. Pribolab Company Information
Table 113. Pribolab Introduction and Business Overview
Table 114. Pribolab Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Pribolab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 116. Pribolab Recent Development
Table 117. Jiangsu Suwei Micro-Biology Research Company Information
Table 118. Jiangsu Suwei Micro-Biology Research Introduction and Business Overview
Table 119. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 121. Jiangsu Suwei Micro-Biology Research Recent Development
Table 122. Shandong Lvdu Bio-Sciences & Technology Company Information
Table 123. Shandong Lvdu Bio-Sciences & Technology Introduction and Business Overview
Table 124. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 126. Shandong Lvdu Bio-Sciences & Technology Recent Development
Table 127. Jiangsu Wisdom Engineering & Technology Company Information
Table 128. Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
Table 129. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 131. Jiangsu Wisdom Engineering & Technology Recent Development
Table 132. BIOCOMMA Company Information
Table 133. BIOCOMMA Introduction and Business Overview
Table 134. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 136. BIOCOMMA Recent Development
Table 137. Femdetection Company Information
Table 138. Femdetection Introduction and Business Overview
Table 139. Femdetection Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Femdetection Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 141. Femdetection Recent Development
Table 142. Wuhan Huamei Wisherkon Biotech Company Information
Table 143. Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
Table 144. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 146. Wuhan Huamei Wisherkon Biotech Recent Development
Table 147. Changsha Huaxue Biological Technology Company Information
Table 148. Changsha Huaxue Biological Technology Introduction and Business Overview
Table 149. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 151. Changsha Huaxue Biological Technology Recent Development
Table 152. Anavo Company Information
Table 153. Anavo Introduction and Business Overview
Table 154. Anavo Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Anavo Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 156. Anavo Recent Development
Table 157. Shandong Vnya Bio-technology Company Information
Table 158. Shandong Vnya Bio-technology Introduction and Business Overview
Table 159. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 161. Shandong Vnya Bio-technology Recent Development
Table 162. Guanyibio Company Information
Table 163. Guanyibio Introduction and Business Overview
Table 164. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 166. Guanyibio Recent Development
Table 167. Prufunglab Company Information
Table 168. Prufunglab Introduction and Business Overview
Table 169. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 170. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 171. Prufunglab Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Fumonisins Immunoaffinity Columns (IAC) Downstream Customers
Table 175. Fumonisins Immunoaffinity Columns (IAC) Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Fumonisins Immunoaffinity Columns (IAC) Product Picture
Figure 2. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Fumonisins Immunoaffinity Columns (IAC) Sales Price (2019-2030) & (US$/Unit)
Figure 6. Fumonisins Immunoaffinity Columns (IAC) Report Years Considered
Figure 7. Global Fumonisins Immunoaffinity Columns (IAC) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Fumonisins Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Fumonisins Immunoaffinity Columns (IAC) Revenue in 2023
Figure 10. Fumonisins Immunoaffinity Columns (IAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 80% Below Picture
Figure 12. 80-90% Picture
Figure 13. 91-100% Picture
Figure 14. 100% Above Picture
Figure 15. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Grains
Figure 21. Product Picture of Feed
Figure 22. Product Picture of Others
Figure 23. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume (%), (2019-2030)
Figure 40. United States Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 46. China Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 48. China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 58. India Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 60. India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 61. Fumonisins Immunoaffinity Columns (IAC) Industrial Chain
Figure 62. Fumonisins Immunoaffinity Columns (IAC) Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Fumonisins Immunoaffinity Columns (IAC) Market Trends
Table 2. Fumonisins Immunoaffinity Columns (IAC) Market Drivers & Opportunity
Table 3. Fumonisins Immunoaffinity Columns (IAC) Market Challenges
Table 4. Fumonisins Immunoaffinity Columns (IAC) Market Restraints
Table 5. Global Fumonisins Immunoaffinity Columns (IAC) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Fumonisins Immunoaffinity Columns (IAC) Revenue Market Share by Company (2019-2024)
Table 7. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Fumonisins Immunoaffinity Columns (IAC) Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Fumonisins Immunoaffinity Columns (IAC) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Fumonisins Immunoaffinity Columns (IAC)
Table 13. Global Fumonisins Immunoaffinity Columns (IAC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fumonisins Immunoaffinity Columns (IAC) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Fumonisins Immunoaffinity Columns (IAC) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024) & (%)
Table 44. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030) & (%)
Table 45. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume, (2025-2030) & (K Units)
Table 57. Gold Standard Diagnostics Horsham Company Information
Table 58. Gold Standard Diagnostics Horsham Introduction and Business Overview
Table 59. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 61. Gold Standard Diagnostics Horsham Recent Development
Table 62. LCTech Company Information
Table 63. LCTech Introduction and Business Overview
Table 64. LCTech Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. LCTech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 66. LCTech Recent Development
Table 67. Shimadzu Company Information
Table 68. Shimadzu Introduction and Business Overview
Table 69. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Shimadzu Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 71. Shimadzu Recent Development
Table 72. Biotez Berlin Company Information
Table 73. Biotez Berlin Introduction and Business Overview
Table 74. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 76. Biotez Berlin Recent Development
Table 77. PerkinElmer Company Information
Table 78. PerkinElmer Introduction and Business Overview
Table 79. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 81. PerkinElmer Recent Development
Table 82. VICAM Company Information
Table 83. VICAM Introduction and Business Overview
Table 84. VICAM Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. VICAM Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 86. VICAM Recent Development
Table 87. Ring Biotechnology Company Information
Table 88. Ring Biotechnology Introduction and Business Overview
Table 89. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 91. Ring Biotechnology Recent Development
Table 92. R-Biopharm AG Company Information
Table 93. R-Biopharm AG Introduction and Business Overview
Table 94. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 96. R-Biopharm AG Recent Development
Table 97. CHROMATIFIC Company Information
Table 98. CHROMATIFIC Introduction and Business Overview
Table 99. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 101. CHROMATIFIC Recent Development
Table 102. Neogen Company Information
Table 103. Neogen Introduction and Business Overview
Table 104. Neogen Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Neogen Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 106. Neogen Recent Development
Table 107. Shandong Meizheng Bio-Tech Company Information
Table 108. Shandong Meizheng Bio-Tech Introduction and Business Overview
Table 109. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 111. Shandong Meizheng Bio-Tech Recent Development
Table 112. Pribolab Company Information
Table 113. Pribolab Introduction and Business Overview
Table 114. Pribolab Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Pribolab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 116. Pribolab Recent Development
Table 117. Jiangsu Suwei Micro-Biology Research Company Information
Table 118. Jiangsu Suwei Micro-Biology Research Introduction and Business Overview
Table 119. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 121. Jiangsu Suwei Micro-Biology Research Recent Development
Table 122. Shandong Lvdu Bio-Sciences & Technology Company Information
Table 123. Shandong Lvdu Bio-Sciences & Technology Introduction and Business Overview
Table 124. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 126. Shandong Lvdu Bio-Sciences & Technology Recent Development
Table 127. Jiangsu Wisdom Engineering & Technology Company Information
Table 128. Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
Table 129. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 131. Jiangsu Wisdom Engineering & Technology Recent Development
Table 132. BIOCOMMA Company Information
Table 133. BIOCOMMA Introduction and Business Overview
Table 134. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 136. BIOCOMMA Recent Development
Table 137. Femdetection Company Information
Table 138. Femdetection Introduction and Business Overview
Table 139. Femdetection Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Femdetection Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 141. Femdetection Recent Development
Table 142. Wuhan Huamei Wisherkon Biotech Company Information
Table 143. Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
Table 144. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 146. Wuhan Huamei Wisherkon Biotech Recent Development
Table 147. Changsha Huaxue Biological Technology Company Information
Table 148. Changsha Huaxue Biological Technology Introduction and Business Overview
Table 149. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 151. Changsha Huaxue Biological Technology Recent Development
Table 152. Anavo Company Information
Table 153. Anavo Introduction and Business Overview
Table 154. Anavo Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Anavo Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 156. Anavo Recent Development
Table 157. Shandong Vnya Bio-technology Company Information
Table 158. Shandong Vnya Bio-technology Introduction and Business Overview
Table 159. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 161. Shandong Vnya Bio-technology Recent Development
Table 162. Guanyibio Company Information
Table 163. Guanyibio Introduction and Business Overview
Table 164. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Guanyibio Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 166. Guanyibio Recent Development
Table 167. Prufunglab Company Information
Table 168. Prufunglab Introduction and Business Overview
Table 169. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 170. Prufunglab Fumonisins Immunoaffinity Columns (IAC) Product Offerings
Table 171. Prufunglab Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Fumonisins Immunoaffinity Columns (IAC) Downstream Customers
Table 175. Fumonisins Immunoaffinity Columns (IAC) Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Fumonisins Immunoaffinity Columns (IAC) Product Picture
Figure 2. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Fumonisins Immunoaffinity Columns (IAC) Sales Price (2019-2030) & (US$/Unit)
Figure 6. Fumonisins Immunoaffinity Columns (IAC) Report Years Considered
Figure 7. Global Fumonisins Immunoaffinity Columns (IAC) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Fumonisins Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Fumonisins Immunoaffinity Columns (IAC) Revenue in 2023
Figure 10. Fumonisins Immunoaffinity Columns (IAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 80% Below Picture
Figure 12. 80-90% Picture
Figure 13. 91-100% Picture
Figure 14. 100% Above Picture
Figure 15. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Fumonisins Immunoaffinity Columns (IAC) Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Grains
Figure 21. Product Picture of Feed
Figure 22. Product Picture of Others
Figure 23. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Fumonisins Immunoaffinity Columns (IAC) Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Fumonisins Immunoaffinity Columns (IAC) Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Fumonisins Immunoaffinity Columns (IAC) Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Fumonisins Immunoaffinity Columns (IAC) Sales Volume (%), (2019-2030)
Figure 40. United States Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 46. China Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 48. China Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 58. India Fumonisins Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 60. India Fumonisins Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 61. Fumonisins Immunoaffinity Columns (IAC) Industrial Chain
Figure 62. Fumonisins Immunoaffinity Columns (IAC) Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232